APA (7th ed.) Citation

PM, F., S, M., L, M., E, R., & JL, N. (2024). Developing a pathway to clinical trials for CACNA1A-related epilepsies: A patient organization perspective. Therapeutic advances in rare disease, 5, 26330040241245725. https://doi.org/10.1177/26330040241245725

Chicago Style (17th ed.) Citation

PM, Fox, Malepati S, Manaster L, Rossignol E, and Noebels JL. "Developing a Pathway to Clinical Trials for CACNA1A-related Epilepsies: A Patient Organization Perspective." Therapeutic Advances in Rare Disease 5 (2024): 26330040241245725. https://doi.org/10.1177/26330040241245725.

MLA (9th ed.) Citation

PM, Fox, et al. "Developing a Pathway to Clinical Trials for CACNA1A-related Epilepsies: A Patient Organization Perspective." Therapeutic Advances in Rare Disease, vol. 5, 2024, p. 26330040241245725, https://doi.org/10.1177/26330040241245725.